Why the study?
This study evaluated the association of the myocardial performance index (MPI) with silent myocardial ischemia (MI) in diabetes and the outcomes of medical management with antiplatelets and beta-blocker therapy.
Does the myocardial performance index (MPI) detect silent myocardial ischemia in patients with diabetes mellitus?
Does the myocardial performance index (MPI) detect silent myocardial ischemia in patients with diabetes mellitus?
An elevated myocardial performance index (>0.5) on echocardiography has high sensitivity (100%) and specificity (91.67%) for detecting silent myocardial ischemia in patients with diabetes mellitus.
Answers are grounded in this paper and cite their sources.
Higher MPI in diabetics may signal silent ischemia; Level 5 data leaves open its added value for screening or therapy guidance.
A BSTRACT Background and Objectives: To study the association of myocardial performance index (MPI) with silent myocardial ischemia (MI) in diabetes, and the outcomes in relation to management of silent MI with antiplatelets and beta-blocker therapy Materials and Methods: This case–control investigation included 30 diabetic patients and 30 healthy controls. Stress ECHO and coronary angiography were performed, and MPI was calculated. Results: MPI was significantly higher in diabetics (0.54 ± 0.08 vs. 0.33 ± 0.02, P < 0.0001). Silent MI was observed in 60% cases. Compared to those without silent MI, patients with silent MI had significantly higher MPI (0.59 ± 0.06 vs. 0.46 ± 0.05, P < 0.0001). An MPI cutoff of > 0.5 detected silent MI in 96.67% cases, with 100% sensitivity and 91.67% specificity. Conclusion: Elevated MPI detects silent MI in diabetics, supporting effective management strategies.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: